Nicole Laferriere Selected Research

Nicole Laferriere Research Topics

4	Neoplasms (Cancer) 12/2021 - 03/2009
2	Breast Neoplasms (Breast Cancer) 12/2021 - 08/2009
2	Hemorrhage 07/2021 - 06/2018
2	Hemophilia A (Haemophilia) 02/2020 - 06/2018
2	Erectile Dysfunction 01/2005 - 05/2004
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024
1	Synovitis 10/2021
1	Postoperative Pain 09/2018
1	Joint Diseases (Joint Disease) 06/2018
1	Metrorrhagia (Spotting) 06/2018
1	Infections 06/2018
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2017
1	Thrombosis (Thrombus) 12/2015
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2015
1	Nausea 03/2009
1	Fatigue 03/2009
1	Exanthema (Rash) 03/2009
1	Diarrhea 03/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2009
1	Anorexia 03/2009
1	Kidney Neoplasms (Kidney Cancer) 03/2009

3	Factor VIII (Coagulation Factor VIII)IBA 07/2021 - 06/2018
2	Sorafenib (BAY 43-9006)FDA Link 08/2009 - 03/2009
2	Vardenafil Dihydrochloride (Levitra)FDA Link 01/2005 - 05/2004
1	Rituximab (Mabthera)FDA Link 01/2024
1	venetoclaxIBA 01/2024
1	HemosiderinIBA 10/2021
1	Blood Group Antigens (Blood Groups)IBA 07/2021
1	Narcotics (Narcotic Analgesics)IBA 09/2018
1	Blood Coagulation Factors (Coagulation Factor)IBA 06/2018
1	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2015
1	Tyrosine Kinase InhibitorsIBA 04/2010
1	Capecitabine (Xeloda)FDA Link 04/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2010
1	telatinibIBA 04/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2010
1	Interferon alpha-2 (Roferon-A)FDA Link 03/2009
1	Phosphodiesterase 5 InhibitorsIBA 01/2005
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2005